Gene therapy offers hope for rare immune disorder
NCT ID NCT03837483
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests a gene therapy for people with Wiskott-Aldrich syndrome, a rare genetic disease that weakens the immune system and causes bleeding. The treatment uses the patient's own blood stem cells, which are modified in a lab to fix the faulty gene and then returned to the body. The goal is to reduce severe infections and bleeding episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WISKOTT-ALDRICH SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Healthcare of Atlanta, Inc
Atlanta, Georgia, 30329, United States
-
Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR-TIGET)
Milan, 20132, Italy
Conditions
Explore the condition pages connected to this study.